Yunjie Zhao - Publications

JOSD2 alleviates hypertensive renal disease through deubiquitinating AKT in renal tubular epithelial cells.

Journal: Cellular signalling

Published: September 17, 2025

Facile synthesis and biological evaluation of [a]-benzannulated BODIPY derivatives as novel heavy-atom-free photosensitizers for photodynamic anticancer therapy.

Journal: Bioorganic chemistry

Published: April 28, 2025

Carnosol attenuates Ang II-induced renal injury by p62-KEAP1-NRF2 signaling pathway.

Journal: Toxicology and applied pharmacology

Published: March 21, 2025

Corrigendum to "Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer" [Eur. J. Med. Chem. 259 (2023) 115703/5].

Journal: European journal of medicinal chemistry

Published: February 17, 2024

Nucleotides as new co-formers in co-amorphous systems: Enhanced dissolution rate, water solubility and physical stability.

Journal: European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V

Published: February 01, 2024

Design, synthesis, and biological evaluation of 1,6-naphthyridine-2-one derivatives as novel FGFR4 inhibitors for the treatment of colorectal cancer.

Journal: European journal of medicinal chemistry

Published: April 24, 2023

Dissolution changes in drug-amino acid/biotin co-amorphous systems: Decreased/increased dissolution during storage without recrystallization.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: April 22, 2023

Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2/TAK1 signaling pathway.

Journal: Cell death & disease

Published: December 07, 2022

cyy-287, a novel pyrimidine-2,4-diamine derivative, inhibits tumor growth of EGFR-driven non-small cell lung cancer via the ERK pathway.

Journal: Acta biochimica et biophysica Sinica

Published: October 14, 2022

cyy260 suppresses the proliferation, migration and tumor growth of osteosarcoma by targeting PDGFR-β signaling pathway.

Journal: Chemico-biological interactions

Published: August 13, 2022

Macrophage-specific MyD88 deletion and pharmacological inhibition prevents liver damage in non-alcoholic fatty liver disease via reducing inflammatory response.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: April 19, 2022

Discovery of Potent and Orally Bioavailable Platelet-Derived Growth Factor Receptor (PDGFR) Inhibitors for the Treatment of Osteosarcoma.

Journal: Journal of medicinal chemistry

Published: March 03, 2022